89 studies found for:    THPO
Show Display Options
Rank Status Study
1 Recruiting Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Condition: Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: Eltrombopag
2 Completed Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
Conditions: Germ Cell Tumors;   Hepatic Cancer;   Neuroblastoma;   Osteosarcoma;   Rhabdomyosarcoma
Intervention: Drug: Recombinant Human Thrombopoietin
3 Withdrawn Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: recombinant human thrombopoietin (rhTPO); rituximab;   Drug: Dexamethasone
4 Completed An Investigation of rhTPO With Different Frequencies in the Management of ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Recombinant Human Thrombopoietin (rhTPO)
5 Recruiting Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
Conditions: Thrombocytopoietin;   Hematopoietic Stem Cell Mobilization;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Recombinant Human Thrombopoietin
6 Not yet recruiting Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: rhTPO;   Drug: placebo
7 Not yet recruiting The Effect of Recombinant Human Thrombopoietin on Septic Shock With Thrombocytopenia.
Conditions: Sepsis;   Thrombocytopenia
Interventions: Drug: rhTPO;   Drug: Placebo
8 Unknown  Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
Condition: Immune Thrombocytopenia Response to Thrombopoietin Mimetics
Intervention:
9 Recruiting Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Romiplostin
10 Completed Thrombopoietin Levels and Platelet Transfusion in Neonates
Condition: Thrombocytopenia
Intervention:
11 Active, not recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic;   Thrombocytopenia
Interventions: Drug: Eltrombopag (Promacta);   Drug: Eltrombopag
12 Completed rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: recombinant human thrombopoietin (rhTPO); dexamethasone;   Drug: Dexamethasone
13 Completed Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rhTPO in combination with Rituximab
14 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Intervention: Drug: Eltrombopag
15 Withdrawn A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Cyclosporin A;   Drug: rhTPO
16 Recruiting Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
Condition: Thrombocytopenia
Intervention: Drug: recombinant human thrombopoietin
17 Recruiting Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
18 Completed SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
Condition: Thrombocytopaenia
Interventions: Drug: SB497115;   Other: Placebo
19 Recruiting Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation;   Myeloablative;   Delayed Platelet Engraftment
Intervention: Drug: Recombinant Human Thrombopoietin (rHTPO)
20 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.